GEN Exclusives

More »

GEN News Highlights

More »
Apr 16, 2008

Bio-Bridge and JRS to Form a Joint Venture for Biomaterial Supply in China

  • Bio-Bridge Science and JR Scientific report plans to invest RMB 10 million, or $1.43 million, to set up a joint venture that will supply biomaterials in China and other countries.

    The firms signed a a nonbinding memorandum of understanding to effect the formation of the JV, which will be carried out with other investors in China. JRS has agreed to transfer technology and know-how to the JV. The new entity will produce culture medium, serum, and other biomaterials for sale.

    The JV will serve as a source of revenue for Bio-Bridge. With an HIV-PV vaccine for prevention and treatment of HIV in preclinical testing, Bio-Bridge will also gain a new supplier for the relevant vaccine material.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »